PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 3, 2020JAMA Oncology1,162 citationsOpen Access

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

View Full Paper
KSKohei ShitaraECEric Van CutsemYBYung‐Jue Bang

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifier: NCT02494583.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shitara et al. (2020) studied this question.

synapsesocial.com/papers/6914b9ff93f9c2bcff9a5c4ehttps://doi.org/10.1001/jamaoncol.2020.3370
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group2006 · 1,944 citations
  2. 2Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist2019 · 15 citations
  3. 3Toxicity and response criteria of the Eastern Cooperative Oncology Group1982 · 11,796 citations
  4. 4Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer2017 · 133 citations
  5. 5Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model2016 · 69 citations